text
"['\n3. 타법인출자 현황(상세)\n☞ 본문 위치로 이동\n(기준일 :\xa0\n2023년 06월 30일\n)\n(단위 : 백만원, 주, %)\n법인명\n상장여부\n최초취득일자\n출자목적\n최초취득금액\n기초잔액\n증가(감소)\n기말잔액\n최근사업연도재무현황\n수량\n지분율\n장부가액\n취득(처분)\n평가손익\n수량\n지분율\n장부가액\n총자산\n당기순손익\n수량\n금액\n한국콜마(주)\xa0\n상장\n2012.10.02\n경영참여\n112,434\n6,209,889\n27.14\n265,441\n-\n-\n-\n6,209,889\n27.14\n265,441\n1,158,797\n-26,433\n콜마비앤에이치(주)\n상장\n2004.02.26\n경영참여\n510\n13,129,267\n44.44\n15,569\n-\n-\n-\n13,129,267\n44.44\n15,569\n489,435\n37,606\n모노랩스(주)\xa0\n비상장\n2018.08.09\n단순투자\n250\n4,280\n2.90\n250\n-\n-\n-\n4,280\n2.90\n250\n12,536\n-4,388\n에이치케이바이오이노베이션㈜\n비상장\n2019.07.29\n경영참여\n20,397\n3,448,276\n57.00\n10,312\n-3,448,276\n-10,312\n-\n-\n-\n-\n16,695\n-2,323\n(주)넥스트앤바이오\n비상장\n2020.01.01\n경영참여\n1,012\n7,808\n46.31\n11,227\n-\n-\n-\n7,808\n46.31\n11,227\n3,450\n-3,858\n(주)플래닛147\n비상장\n2020.12.14\n경영참여\n3,800\n152,000\n100.00\n3,800\n-\n-\n-\n152,000\n100.00\n3,800\n3,342\n-446\n콜마글로벌(주)\xa0\n비상장\n2020.12.14\n경영참여\n10,000\n520,000\n100.00\n3,383\n120,000\n3,000\n-\n640,000\n100.00\n6,383\n2,148\n-55\nHK Innovers USA, Inc.\n비상장\n2022.06.09\n경영참여\n12\n\xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 10\n100.00\n12\n-\n-\n-\n10\n100.00\n12\n6\n-7\n콜마유엑스(주)\xa0\n비상장\n2022.07.01\n경영참여\n6,014\n60,000\n100.00\n6,014\n-\n-\n-\n60,000\n100.00\n6,014\n14,649\n279\n(주)농우바이오(주3)\n상장\n2014.10.23\n단순투자\n299\n11,800\n-\n102\n-\n-\n1\n11,800\n-\n103\n278,074\n4,832\n네오아티잔(주)\xa0\n비상장\n2015.08.17\n단순투자\n1,000\n120,681\n4.02\n241\n-\n-\n-\n120,681\n4.02\n241\n9,996\n-1,079\n이노이브코리아㈜\n비상장\n2012.06.30\n단순투자\n200\n50,400\n16.24\n-\n-\n-\n-\n50,400\n16.24\n-\n-\n-\n(주)크레이버코퍼레이션 보통주\n비상장\n2018.10.23\n단순투자\n300\n4,731\n0.39\n-\n-\n-\n-\n4,731\n0.39\n-\n16,574\n4\n(주)크레이버코퍼레이션 RCPS\n비상장\n2018.10.23\n단순투자\n2,400\n32,171\n2.67\n375\n-\n-\n-\n32,171\n2.67\n375\n16,574\n4\nPRIMER SAZZE FUND Ⅰ\n비상장\n2019.12.11\n단순투자\n2,176\n2,500\n5.83\n2,882\n-\n-\n-\n2,500\n5.83\n2,882\n136,973\n49,786\n(주)비모뉴먼트\n비상장\n2020.07.21\n단순투자\n1,999\n88,532\n4.04\n4,388\n-\n-\n-\n88,532\n4.04\n4,388\n37,278\n12,622\n(주)컬쳐앤커머스\n비상장\n2021.05.17\n단순투자\n300\n\xa0 \xa0 \xa0 \xa028,251\n5.43\n343\n-\n-\n-\n28,251\n5.43\n343\n3,764\n-528\n(주)레이어즈\n비상장\n2021.04.22\n단순투자\n1,500\n\xa0 \xa0 \xa050,000\n8.33\n740\n-\n-\n-\n50,000\n8.33\n740\n4,244\n287\n(주)노바셀테크놀로지\n비상장\n2021.07.22\n단순투자\n1,000\n\xa0 \xa0 \xa0100,000\n0.97\n1,202\n-\n-\n-\n100,000\n0.97\n1,202\n14,083\n-8,568\n(주)셀인셀즈\n비상장\n2021.07.19\n단순투자\n2,000\n\xa0 \xa03,901\n4.01\n2,003\n-\n-\n-\n3,901\n4.01\n2,003\n6,436\n-4,163\n(주)지아이셀\n비상장\n2021.09.15\n단순투자\n5,000\n\xa0 238,096\n1.95\n5,293\n-\n-\n-\n238,096\n1.95\n5,293\n60,277\n-30,129\n(주)다인메디컬그룹\n비상장\n2022.01.13\n단순투자\n1,002\n\xa0 \xa0 \xa0 \xa0 \xa0 \xa0 758\n10.71\n2,250\n-\n-\n-\n758\n10.71\n2,250\n2,260\n-2,359\n(주)럽맘\n비상장\n2022.05.26\n단순투자\n500\n200,000\n9.09\n522\n-\n-\n-\n200,000\n9.09\n522\n114\n-164\n(주)올라운드닥터스\n비상장\n2022.06.02\n단순투자\n1,000\n15,008\n8.33\n1,000\n-\n-\n-\n15,008\n8.33\n1,000\n945\n-414\nMomenti Inc. (주2)\n비상장\n2022.04.19\n단순투자\n2,489\n-\n-\n8,999\n-\n-\n-\n-\n-\n8,999\n897\n-1,978\n(주)바이옴에이츠 (주1)\n비상장\n2023.01.05\n단순투자\n500\n-\n-\n-\n1,500\n500\n-\n1,500\n6.66\n500\n-\n-\nKB 글로벌 플랫폼 2호 펀드 (주1)\n비상장\n2023.03.30\n단순투자\n800\n-\n-\n-\n-\n800\n-\n-\n-\n800\n-\n-\n㈜라이프사이언스테크놀로지(보통주) (주1)\n비상장\n2023.02.28\n단순투자\n731\n-\n-\n-\n533,624\n731\n-\n553,624\n11.40\n731\n-\n-\n㈜라이프사이언스테크놀로지(RCPS) (주1)\n비상장\n2023.02.28\n단순투자\n377\n-\n-\n-\n200,000\n377\n-\n200,000\n4.12\n377\n-\n-\n안다H 프로젝트 일반사모투자신탁 제8호 (주1)\n비상장\n2023.05.09\n단순투자\n1,000\n-\n-\n-\n-\n1,000\n-72\n-\n-\n928\n-\n-\n아이비케이씨-마이다스 밸류크리에이션 신기술사업투자조합 (주1)\n비상장\n2023.05.10\n단순투자\n95\n-\n-\n-\n-\n95\n-\n-\n-\n95\n-\n-\n합 계\n24,478,359\n-\n346,348\n-2,573,152\n-3,809\n-71\n21,905,207\n-\n342,468\n2,289,547\n18,528\n주1) 당기 중 신규투자하였습니다.주2) 피투자자가 후속 투자를 받는 경우, 계약에 따라 당사는 피투자자로부터 우선주를 발행받기로 한 조건부 지분 인수계약입니다.주3) 상기 지분상품은 지분율이 미미하므로 지분율의 표기를 생략하였습니다.\n']"
